Skip to main content
. 2016 Dec 2;31(5):1117–1122. doi: 10.1038/leu.2016.316

Table 2. Characteristics of bleeding and nonbleeding patients.

Characteristic Bleeding No bleeding P-value
Total number (n=64) 39/64 (60.9%) 25/64 (39.1%) NA
Median body weight, kg (range) 74 (48–108) 69.5 (44–114) 0.49
Male, % 64.1% 64% 0.99
Antiplatelet or anticoagulant Tx 13/39 (33.3%) 5/25 (20%) 0.25
Antiplatelet therapy 8/39 (20.5%) 4/25 (16%) 0.65
Oral AC/heparin 6/39 (15.4%) 1/25 (4%) 0.15
Median platelet count, G/l (range) 116.5 (38–303) 137 (51–328) 0.0012
Median hemoglobin, mg/dl (range) 12.6 (9.2–16.7) 12.1 (8.3–17.1) 0.16
Median WBC, G/l (range) 21.8 (4.3–347.8) 16.0 (2.2–397) 0.41

Abbreviations: AC, anticoagulant; NA, not available; Tx, treatment; WBC, white blood cell count. Bold value indicates significant P-value.